This is the retrospective cohort study which was conducted to analyse the impact of ART on labour force participation by 2829 PLWHA using ART at in Tanzania from 2005 to 2011. Quantitative method of research was applied and review of patients’ record was used to collect data. The results revealed that 92.4% of PLWHA registered on ART belong to working age group i.e. 15 – 65 years old (t-statistical value = 4.9 and p - value = 0.0002). There were 92.0% PLWHA who were able to work before ART, but labour force increased to 99.5% after PLWHA initiated on ART (correlation coefficient, r = 0.999, p-value < 0.001). The researcher concluded that majority of PLWHA using ART belongs to the working age group, and ART increases PLWHA labour force pa...
To determine whether earlier initiation of antiretroviral therapy (ART) is associated with better ec...
BACKGROUND: International targets for access to antiretroviral therapy (ART) have over-estimated the...
BACKGROUND: UNAIDS calls for fewer than 500,000 new HIV infections/year by 2020, with treatment-as-p...
BACKGROUND: The Tanzanian Government started scaling up its antiretroviral treatment (ART) program f...
The Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral...
The Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral...
The Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral...
ObjectiveTo assess changes and equity in antiretroviral therapy (ART) use in Kenya and South Africa....
Background. Clinical benefits of ART are well documented, but less is known about its effects on eco...
OBJECTIVE: To determine mortality and retention in ART programmes in Tanzania, between 2010 and 2013...
BACKGROUND: Sub-Saharan countries bear a disproportionate percentage of HIV infections and HIV-relat...
Background: Substantial falls in the mortality of people living with HIV (PLWH) have been observed s...
BACKGROUND: Lablite is an implementation project supporting and studying decentralized antiretrovira...
Using longitudinal survey data collected in Kenya, this paper estimates the longer-term impacts of a...
Magister Public Health - MPHBackground: Human Immune Deficiency Virus (HIV) is a public health chall...
To determine whether earlier initiation of antiretroviral therapy (ART) is associated with better ec...
BACKGROUND: International targets for access to antiretroviral therapy (ART) have over-estimated the...
BACKGROUND: UNAIDS calls for fewer than 500,000 new HIV infections/year by 2020, with treatment-as-p...
BACKGROUND: The Tanzanian Government started scaling up its antiretroviral treatment (ART) program f...
The Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral...
The Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral...
The Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral...
ObjectiveTo assess changes and equity in antiretroviral therapy (ART) use in Kenya and South Africa....
Background. Clinical benefits of ART are well documented, but less is known about its effects on eco...
OBJECTIVE: To determine mortality and retention in ART programmes in Tanzania, between 2010 and 2013...
BACKGROUND: Sub-Saharan countries bear a disproportionate percentage of HIV infections and HIV-relat...
Background: Substantial falls in the mortality of people living with HIV (PLWH) have been observed s...
BACKGROUND: Lablite is an implementation project supporting and studying decentralized antiretrovira...
Using longitudinal survey data collected in Kenya, this paper estimates the longer-term impacts of a...
Magister Public Health - MPHBackground: Human Immune Deficiency Virus (HIV) is a public health chall...
To determine whether earlier initiation of antiretroviral therapy (ART) is associated with better ec...
BACKGROUND: International targets for access to antiretroviral therapy (ART) have over-estimated the...
BACKGROUND: UNAIDS calls for fewer than 500,000 new HIV infections/year by 2020, with treatment-as-p...